Skip to main content
VCbacked
Log inGet Started

Nanotronics Imaging

New York, United States

Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.

$55.8M raised
Mar 2022
Venture - Series Unknown
Life ScienceMedical DeviceNanotechnologySoftware

Top Investors

Founders FundSahin BoydasInvestment Corporation of Dubai (ICD)8090 PartnersJim Pitkow

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nanotronics Imaging

How much funding has Nanotronics Imaging raised?
Nanotronics Imaging has raised $55.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2022.
Who are Nanotronics Imaging's investors?
Nanotronics Imaging's investors include Founders Fund, Sahin Boydas, Investment Corporation of Dubai (ICD), 8090 Partners, Jim Pitkow.
Where is Nanotronics Imaging headquartered?
Nanotronics Imaging is headquartered in New York, United States.
What does Nanotronics Imaging do?
Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
What stage is Nanotronics Imaging at?
Nanotronics Imaging is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Nanotronics Imaging — Funding & Investors." VCBacked, March 14, 2022, https://www.vcbacked.co/company/nanotronics-imaging. Accessed July 2, 2026.
APA
VCBacked. (2022). Nanotronics Imaging — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nanotronics-imaging
Wikipedia (cite web)
{{cite web |title=Nanotronics Imaging — Funding & Investors |url=https://www.vcbacked.co/company/nanotronics-imaging |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Life Science

View all
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Bluephage
Barcelona$1.5M
Alphina Therapeutics
Westport$40.0M
Neuroglee Therapeutics
Singapore$10.0M
Navrogen
Philadelphia